Pharmacotherapy meetings & conferences

25th Annual Psychiatric Pharmacotherapy Update

October 24 & 25, 2013 Austin, Texas

The University of Texas at Austin College of Pharmacy is proud to be hosting the 25th Annual Psychiatric Pharmacotherapy Update, October 24 & 25, 2013 in Austin, Texas.  This educational conference is presented by the College of Pharmacy's Continuing Pharmacy Education department and Psychiatric Pharmacy Program to meet the educational needs of practitioners who provide care to patients with mental health disorders.

Addressing Psychiatric Pharmacotherapy Topics Important for Today's Practice

This conference's goal is improve the quality of care delivered to people with mental health problems by providing timely and clinically useful information for the practicing clinician. Conference speakers focus on the practical application of neuroscience principles and evidence-based approaches to the treatment of serious and persistent major psychiatric and neurologic disorders, including depression, schizophrenia, bipolar, and dementias. Participants are provided with treatment advances in the psychiatric pharmacotherapy of children, traumatic brain injury, substance abuse, and an update on new psychotherapeutic uses of existing agents and new psychotropic agents that will impact your practice in the next year.

Inter-Professional

• Pharmacists

• Psychiatrists

• Physicians

• Nurses

• Psychologists

• Social Workers & Counselors

Who Should Attend

Pharmacists, psychiatrists, physicians, nurses, psychologists and social workers who specialize in or have an interest in neuropsychiatric disorders and wish to enhance their awareness and knowledge of the most recent advances impacting contemporary practice. 

5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus

21-24 November, 2013 Bangkok, Thailand

Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.

Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often  necessary to reach  early and sustained achievement of individualized  glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.

The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.

List of Topics

•  Treatment Simplification and Compliance

•  FDCs as First Step Treatment

•  FDC in Secondary Prevention

•  FDCs of Antihypertensive and Antidiabetic Drugs

•  FDCs of Antihypertensive and Lipid Lowering Drugs

•  FDC in the Elderly and Very Elderly

•  Ambulatory BP in the Assessment of FDC Efficacy

•  Home BP in the Assessment of FDC Efficacy

•  Combinations with Thiazides. Chlortalidone vs HCTZ

•  ACE Inhibitors  and  Diuretics FDC

•  ACE Inhibitors  and  Calcium Channel Blockers FDC

•  ARBs  and Diuretics  FDC

•  ARBs  and Calcium Channel Blockers  FDC

•  Triple Drug Combinations

•  The Polypills

•  FDCs as Generic Drugs

•  Guidelines

•  FDCs in Different Countries

•  Regulatory Aspects

•  Cost Issues

Contact Us

Conference Organizers

Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel:  +41 (0)22 533 0948    
Fax: +41 (0)22 580 2953

General Enquiries

Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com  
Fax: +41 (0)22 580 2953

The Management and Treatment of Personality Disorder: Evidence Updates

6th June 2013 London, United Kingdom

Conference theme

This conference will help healthcare and other professionals to maximize their treatment impact by learning about the current evidence-based best practices for working with people with personality disorder. Through presentations by and discussions with experts in the field, delegates will gain a greater understanding of the issues relevant to the management and treatment of this client group.

The conference format offers opportunities for delegates to ask questions about issues important to them, and those attending should come prepared to raise points for open discussion. The intended outcome of this event is that delegates will be better informed about personality disorder and so will be able to design and deliver interventions that are of maximum benefit for service users.

The conference will highlight the following:

The health burden of personality disorder

What works with personality disorder

Pharmacotherapy with personality disorder

Service user led initiatives

Competencies for working with people with personality disorder

Perspectives from service users

The therapeutic value of creative approaches in treatment

Integrated treatment

Target Audience:

Psychiatrists

Psychologists

Social Workers

Probation Officers

Occupational Therapists

Mental Health Nurses

Service Managers

Service Users

Reduced rates for Students, Residents, Nursing practitioners

Contact Us

Address in United Kingdom:

Conferences & Congresses LTD.
Trading as MEDINEO
Lawford House,
Albert Place,
London,
N3 1RL,
United Kingdom

Phone: +44 207 617 7374
Fax: +44 870 330 5859

Email:  info@medineo.org